Pfizer Applies to Expand License of Its COVID-19 Vaccine for 12-15 Years Age Group

WASHINGTON (Sputnik) - Pfizer-BioNTech has submitted an application to the US Food and Drug Administration (FDA) to expand the license of its two-dose COVID-19 vaccine for 12-15-year-old adolescents, the companies said in a joint press release.